Form 8-K Context Therapeutics For: Oct 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Context Therapeutics expands share offering program to $75 million
October 24, 2025 4:04 PM EDTContext Therapeutics Inc. (NASDAQ: CNTX) amended its at-the-market equity offering program on October 24, 2025, expanding the aggregate offering amount to $75 million from its previous limit, according to a company statement.
The biotechnology company entered into Amendment No. 1 to its existing Sales Agreement with... More
